Hiring?
Logo

Antimicrobial Technology

location_on

Singapore, Singapore

Short Summary

Nanotec Preventive Healthcare provides Antimicrobial products to ensure that humans and animals are free from infections caused by contact with surfaces contaminated by bacteria and fungus.

Overview

Target
1'300'000CHF
Minimum
17'000CHF
Investment Raised
410'000CHF
Previous Rounds CHF410,000
Stage Achieving Sales
Investor Role Silent

Highlights

  • Strong credentials of founding shareholders
  • Our product with prolonged use, does not cause antibiotic resistance
  • Generating revenues from Petcare sector with many positive responses
  • Preliminary orders of wall coatings from ESG Shanghai, LEED Specialists
  • Already raised S$600k, working on to raise another S$1m
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Featured
17% raised

MyCLNQ-Digital Health

location_on Singapore, Singapore

MyCLNQ-"Connecting all your Healthcare needs" An unique one stop solution for betterment of community. MyCLNQ has automated booking system for medical appointments; Non-Emergency Medical Transport booking; Marketplace for medical equipment/produc...

690'000 CHF

Target

69'000 CHF

Min per Investor

Global Pro
0% raised

real anti aging company

location_on New Zealand

Ageing is a disease. Ageing is a Telomere shorten disease. Lengthening Telomere is the right way to cure ageing. Defytime is the best company of Telomere lengthening expert.

2'000'000 CHF

Target

69'000 CHF

Min per Investor

Global Pro
30% raised

Cannabinoid Biotechnology

location_on West, USA

Emerald Health Pharmaceuticals; a biotech company entering Phase 2 human studies with patented unique cannabinoid science & technology focused on diseases like multiple sclerosis and Parkinson's disease; 180+ yrs mgt-team experience; $16M raised.

9'700'000 CHF

Target

4'800 CHF

Min per Investor

load one similar proposal